Systems and methods for color compensation in multi-view video
    1.
    发明授权
    Systems and methods for color compensation in multi-view video 有权
    多视图视频中色彩补偿的系统和方法

    公开(公告)号:US09264689B2

    公开(公告)日:2016-02-16

    申请号:US13412730

    申请日:2012-03-06

    申请人: Dong Li Qun Sun

    发明人: Dong Li Qun Sun

    摘要: An apparatus and a method for color compensation in multi-view video is provided. Video sequences corresponding to a common scene of interest are captured and processed using the master and slave channels respectively. A compensation gain is calculated based on a set of global color ratio statistics obtained from the master and slave channels. The compensation gain is applied to the slave channel. An initial master color correction matrix is combined with a master color matching matrix to obtain a final master color correction matrix. The initial slave color correction matrix is combined with a slave color matching matrix to obtain a final slave color correction matrix. The master and gain-compensated slave channels are color-compensated by applying the final master and final slave color correction matrices to the master and gain-compensated slave channels, respectively.

    摘要翻译: 提供了一种用于多视点视频中的色彩补偿的装置和方法。 使用主通道和从通道分别捕获并处理与感兴趣的共同场景相对应的视频序列。 基于从主通道和从通道获得的一组全局色彩比率计算补偿增益。 补偿增益应用于从通道。 将初始主色彩校正矩阵与主色匹配矩阵组合以获得最终主色彩校正矩阵。 将初始从色彩校正矩阵与从属色匹配矩阵组合以获得最终的从色校正矩阵。 主和增益补偿的从通道分别通过将最终的主和最后的从色彩校正矩阵应用于主和增益补偿的从通道来进行颜色补偿。

    POLYETHER GLYCOL MANUFACTURING PROCESS
    2.
    发明申请
    POLYETHER GLYCOL MANUFACTURING PROCESS 审中-公开
    聚乙二醇制造工艺

    公开(公告)号:US20140323772A1

    公开(公告)日:2014-10-30

    申请号:US13870449

    申请日:2013-04-25

    申请人: QUN SUN

    发明人: QUN SUN

    IPC分类号: C08G65/20 C08G65/16

    摘要: The present invention relates to an improved process for manufacturing polyether and copolyether glycols by polymerization of a reaction mixture comprising at least one tetrahydrofuran or at least one tetrahydrofuran in the presence of a particular perfluorosulfonic acid resin catalyst comprising a copolymer of tetrafluoroethylene (TFE) or chlorotrifluoroethylene (CTFE) and a monomer of the formula CF2═CF—O—CF2—CF2—SO2F.

    摘要翻译: 本发明涉及通过在包含四氟乙烯(TFE)或氯三氟乙烯的共聚物的特定全氟磺酸树脂催化剂存在下聚合包含至少一种四氢呋喃或至少一种四氢呋喃的反应混合物来制备聚醚和共聚醚二醇的改进方法 (CTFE)和式CF2 = CF-O-CF2-CF2-SO2F的单体。

    Copolyether glycol manufacturing process
    3.
    发明授权
    Copolyether glycol manufacturing process 有权
    共聚乙二醇制造工艺

    公开(公告)号:US08609805B2

    公开(公告)日:2013-12-17

    申请号:US13247794

    申请日:2011-09-28

    IPC分类号: C08G65/20 C08G65/30

    摘要: The present invention provides a highly efficient process for manufacturing copolyether glycol having a mean molecular weight of from about 650 to about 5000 dalton by polymerization of tetrahydrofuran and at least one alkylene oxide in the presence of an acid catalyst and at least one compound containing reactive hydrogen atoms. More particularly, the invention relates to a process for manufacturing copolyether glycol which comprises recycle to the polymerization reaction step of at least a portion of the oligomeric cyclic ether which is co-produced with the copolyether glycol, said process exhibiting an Space Time Yield value of greater than about 0.9.

    摘要翻译: 本发明通过在酸催化剂和至少一种含有反应性氢的化合物存在下,通过四氢呋喃和至少一种烯化氧的聚合来提供平均分子量为约650至约5000道尔顿的共聚醚二醇的高效方法 原子 更具体地说,本发明涉及一种制备共聚醚二醇的方法,该方法包括将与共聚醚二醇共同生产的至少一部分低聚环醚再循环到聚合反应步骤中,所述方法表现出空时收率值 大于0.9。

    Therapeutic agents useful for treating pain

    公开(公告)号:US08604037B2

    公开(公告)日:2013-12-10

    申请号:US13212941

    申请日:2011-08-18

    摘要: A compound of formula: wherein Ar1, A, R3, x, and m are as disclosed herein and Ar2 is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptable salt thereof (a “Benzoazolylpiperazine Compound”), compositions comprising a Benzoazolylpiperazine Compound, and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Benzoazolylpiperazine Compound are disclosed.

    Polyether glycol manufacturing process
    6.
    发明授权
    Polyether glycol manufacturing process 有权
    聚醚二醇制造工艺

    公开(公告)号:US08450450B2

    公开(公告)日:2013-05-28

    申请号:US12859321

    申请日:2010-08-19

    申请人: Qun Sun

    发明人: Qun Sun

    IPC分类号: C08G65/10

    CPC分类号: C08G65/20

    摘要: The present invention relates to an improved process for manufacturing polyether and copolyether glycols by polymerization of a reaction mixture comprising at least one tetrahydrofuran or at least one tetrahydrofuran and at least one other cyclic ether, for example, an alkylene oxide, in the presence of a particular perfluorosulfonic acid resin catalyst comprising a copolymer of tetrafluoroethylene (TFE) or chlorotrifluoroethylene (CTFE) and a monomer of the formula CF2═CF—O—CF2—CF2—SO2F.

    摘要翻译: 本发明涉及通过在包含至少一种四氢呋喃或至少一种四氢呋喃和至少一种其它环醚例如烯化氧的反应混合物的存在下聚合来制备聚醚和共聚醚二醇的改进方法 包括四氟乙烯(TFE)或氯三氟乙烯(CTFE)的共聚物和式CF2 = CF-O-CF2-CF2-SO2F的单体的特定的全氟磺酸树脂催化剂。

    COLOR CORRECTION CIRCUITRY AND METHODS FOR DUAL-BAND IMAGING SYSTEMS
    8.
    发明申请
    COLOR CORRECTION CIRCUITRY AND METHODS FOR DUAL-BAND IMAGING SYSTEMS 有权
    双色成像系统的彩色校正电路和方法

    公开(公告)号:US20120025080A1

    公开(公告)日:2012-02-02

    申请号:US12848086

    申请日:2010-07-30

    IPC分类号: H01L25/00

    CPC分类号: H04N5/332 H04N9/735

    摘要: An imaging system may include a dual-band image sensor that captures visible and near-infrared light and image processing circuitry that performs color corrections on images captured by the dual-band image sensor. The image processing circuitry may analyze each captured image in two different color spaces to determine what type of light source lit each image. The image processing circuitry may determine whether an image was lit by a light source having a relatively high proportion of near-infrared emissions such as an incandescent light, a light source having a relatively low proportion of near-infrared emissions such as a fluorescent light, or a light source having an intermediate proportion of near-infrared emissions such as sunlight or other blackbody radiator. After determining what type of light source lit an image, the image processing circuitry may adjust color balances in that image using a color correction matrix associated with that type of light source.

    摘要翻译: 成像系统可以包括捕获可见光和近红外光的双频带图像传感器和对由双频带图像传感器捕获的图像执行颜色校正的图像处理电路。 图像处理电路可以分析两个不同颜色空间中的每个拍摄图像,以确定点亮每个图像的什么类型的光源。 图像处理电路可以确定图像是否由具有相对高比例的近红外发射的光源照射,例如白炽灯,具有相对较低比例的近红外发射的光源,例如荧光灯, 或具有中等比例的近红外发射的光源例如太阳光或其他黑体散热器。 在确定什么类型的光源点亮图像之后,图像处理电路可以使用与该类型的光源相关联的颜色校正矩阵来调整该图像中的色彩平衡。

    THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN
    10.
    发明申请
    THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN 有权
    治疗药物有用的治疗药物

    公开(公告)号:US20120004217A1

    公开(公告)日:2012-01-05

    申请号:US13205323

    申请日:2011-08-08

    摘要: A compound of formula: wherein Ar1, A, R3, x, and m are as disclosed herein and Ar2 is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptable salt thereof (a “Benzoazolylpiperazine Compound”), compositions comprising a Benzoazolylpiperazine Compound, and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Benzoazolylpiperazine Compound are disclosed.

    摘要翻译: 下式的化合物:其中Ar1,A,R3,x和m如本文所公开,Ar 2是苯并噻唑基,苯并恶唑基或苯并咪唑基或其药学上可接受的盐(“苯并恶唑基哌嗪化合物”),包含苯并恶唑基哌嗪化合物 以及用于治疗或预防疼痛,UI,溃疡,IBD,IBS,成瘾性障碍,帕金森病,帕金森综合征,焦虑,癫痫,中风,癫痫发作,瘙痒症状,精神病,认知障碍,记忆缺陷, 限制性脑功能,亨廷顿氏舞蹈病,肌萎缩性侧索硬化,痴呆,视网膜病变,肌肉痉挛,偏头痛,呕吐,运动障碍或抑郁症,其中包括向有需要的动物施用有效量的苯并恶唑基哌嗪化合物。